Buy, Sell, Or Hold: Cell Therapeutics
By Michael Johnson|January 24, 2012|9:55 am
Cell Therapeutics Inc (NASDAQ:CTIC) is essentially a high risk reward stock as the company's productcandidate Pixuvri may get an opinion from the European Medicines Agency(European version of the FDA) Committee for Medicinal Products for Human U...